LEADER 03219nam  22005415  450 
001 9910887806903321
005 20250807130542.0
010   $a3-031-66590-2
024 7 $a10.1007/978-3-031-66590-5
035   $a(MiAaPQ)EBC31684357
035   $a(Au-PeEL)EBL31684357
035   $a(CKB)36165666400041
035   $a(DE-He213)978-3-031-66590-5
035   $a(EXLCZ)9936165666400041
100   $a20240921d2024      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aImmunomodulators and Biologics in Dermatologic Treatment $eTurning Theory into Practice /$fedited by Neal Bhatia
205   $a1st ed. 2024.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024.
215   $a1 online resource (185 pages)
311 08$a3-031-66589-9 
327   $aIntroduction -- Mechanisms of Action: Targets for Immunomodulators -- Steroid and Non-Steroid Immunomodulators -- Biologics as Immunomodulators -- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators -- Antibiotics and Antimicrobials as Immunomodulators -- Integrative Therapies as Immunomodulators -- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders -- Immunomodulators for Common Dermatologic Disorders -- Prescribing and Advocating for Immunomodulators in Dermatology Practice -- Conclusion.
330   $aThis title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients. .
606   $aDermatology
606   $aMedical sciences
606   $aInternal medicine
606   $aDermatology
606   $aHealth Sciences
606   $aInternal Medicine
615  0$aDermatology.
615  0$aMedical sciences.
615  0$aInternal medicine.
615 14$aDermatology.
615 24$aHealth Sciences.
615 24$aInternal Medicine.
676   $a616.506
702   $aBhatia$b Neal
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910887806903321
996   $aImmunomodulators and Biologics in Dermatologic Treatment$94254705
997   $aUNINA